Subscribe
Magazine
Past Issues
Surveys
Industry Statistics
About Us
Members Only
Best Places to Work
General Interest
Exploration & Development
Drilling & Production
Refining & Processing
Pipelines & Transportation
LNG
Energy Transition
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
PennEnergy Stock Watch
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by NexImmune, Inc.
NexImmune Announces Closing of $3.67 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
February 06, 2024
From
NexImmune, Inc.
Via
GlobeNewswire
Tickers
NEXI
NexImmune Announces $3.67 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
February 02, 2024
From
NexImmune, Inc.
Via
GlobeNewswire
Tickers
NEXI
NexImmune, Yale, and JDRF Extend Research Partnership for Type 1 Diabetes
October 24, 2023
From
NexImmune, Inc.
Via
GlobeNewswire
Tickers
NEXI
NexImmune Announces Presentations at The Society for Immunotherapy of Cancer’s 38th Annual Meeting
October 19, 2023
From
NexImmune, Inc.
Via
GlobeNewswire
Tickers
NEXI
NexImmune Announces 1-for-25 Reverse Stock Split
October 18, 2023
From
NexImmune, Inc.
Via
GlobeNewswire
Tickers
NEXI
NexImmune Announces Workforce Reduction to Enable Continued AIMTM Nanoparticle Platform Development Strategy
August 31, 2023
From
NexImmune, Inc.
Via
GlobeNewswire
Tickers
NEXI
NexImmune Reports Second Quarter 2023 Financial Results and Provides Business Updates
August 10, 2023
From
NexImmune, Inc.
Via
GlobeNewswire
Tickers
NEXI
NexImmune Reports First Quarter 2023 Financial Results and Provides Business Updates
May 15, 2023
From
NexImmune, Inc.
Via
GlobeNewswire
Tickers
NEXI
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.